Research and Development

Showing 15 posts of 9596 posts found.

johnmchutchison3x

Dr John McHutchinson steps down from Gilead with $1.1 million goodbye

July 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Gilead has said that Dr John McHutchison is stepping down after nine years at the firm. Gilead’s Chief Scientific Officer …
pixnio-drone

Autonomous drone successfully delivers temperature-controlled drugs in test programme

July 17, 2019 Research and Development, Sales and Marketing Drones, humanitarian aid, pharma

A humanitarian consortium has successfully completed a testing programme for the delivery of temperature-controlled medicines via the use of unmanned …

NICE greenlights Novartis Kisqali combo in HR+/HER2- advanced breast cancer

July 17, 2019 Manufacturing and Production, Medical Communications, Research and Development Cancer, Kisqali, NICE, Novartis, UK, breast cancer, pharma

Novartis’ Kisqali (ribociclib) has secured recommendation from NICE in combination with fulvestrant, meaning the cyclin-dependent kinase 4 and 6 (CDK4/6) …
roche

Roche signs deal with Skyhawk over molecules that modulate RNA splicing

July 17, 2019 Research and Development Genentech, Roche, Skyhawk, drug development, rna splicing

Roche’s Genentech unit has signed a deal with Massachusetts-based firm Skyhawk Therapeutics to develop and commercialise small molecules that modulate …
genentech_web

Genentech signs $1 billion deal with Sosei over GCPRs

July 17, 2019 Research and Development Genentech, Roche, gcprs, pharma, sosei

Roche’s Genentech has entered into a partnership with Sosei Heptares to develop small molecules and biologics that G protein-coupled receptor …
astrazeneca_plaque

AstraZeneca to switch entire fleet to electric vehicles by 2030

July 17, 2019 Research and Development AstraZeneca, EV100, electric vehicles, environmentalism, pharma, renewables

AstraZeneca has revealed plans to use only electric vehicles by 2030. In joining the EV100 group, AstraZeneca will transfer the …
shutterstock_159488225

Capricor’s share price rockets up by 150% on Phase 2 Duchenne muscular dystrophy success

July 16, 2019 Manufacturing and Production, Research and Development CAP-1002, Capricor Therapeutics, Duchenne Muscular Dystrophy, pharma

Capricor Therapeutics has unveiled impactful new Phase 2 data for its investigational allogeneic cardiosphere-derived cell therapy CAP-1002 in the treatment …
darius_hughes

Darius Hughes, Head of Vaccines Business Unit UK, Pfizer

July 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Darius Hughes, Pfizer, Working Life, biotech, pharma, vaccines

“Vaccines provide a unique opportunity to have a positive effect on hundreds of thousands of people” – Darius Hughes, Head …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

July 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, HPV, NHS, NICE, Novartis, Pfizer, Trump, pharma, vaccines

This week’s most popular story covered news of Trump’s claims that he will introduce an executive order to ensure the …
shutterstock_45634132_0

African measles cases surge by 700%

July 11, 2019 Medical Communications, Research and Development Africa, Médecins Sans Frontières, measles, pharma

The number of cases of measles infection on the African continent has surged by 700%, according to data from the …
neurons-3743011_960_720

Biohaven’s CGPR antagonist migraine treatment beats placebo in Phase 3 trial

July 11, 2019 Research and Development Biohaven, CGPR, clinical trials, headache, migraine, pharma

Connecticut-based firm Biohaven has said its migraine drug rimegepant showed superiority over placebo in a Phase 3 clinical trial. The …

Biocon founders donate £6 million to Glasgow University for new research hub

July 10, 2019 Research and Development

The founders of Biocon India have donated £6 million ($7.5 million) to Glasgow University. John Shaw and his wife Kiran …
dr_kim_branson

GSK hires computational drug design expert Dr Kim Branson as new head of machine learning and AI

July 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

British multinational GlaxoSmithKline have hired computational drug design expert Dr Kim Branson as the company’s new Senior Vice President, Global …
shutterstock_232245868

New diagnostic tool predicts tuberculosis infection with 73% accuracy

July 10, 2019 Research and Development diagnosis, pharma, tuberculosis

A new diagnostic technology has demonstrated the ability to identify human tuberculosis (TB) infection and those at highest risk of …
epipen

Novartis aims to solve EpiPen shortage with generic launch of Symjepi to US pharmacies

July 10, 2019 Manufacturing and Production, Research and Development, Sales and Marketing Mylan, Novartis, Sandoz, US, epipen, pharma

Novartis has announced the immediate availability of its generic epinephrine auto-injector in pharmacies throughout the US, as it moves to …
The Gateway to Local Adoption Series

Latest content